Drug Type Small molecule drug |
Synonyms TAS 3681 |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 1 | United States | 01 Mar 2016 | |
Metastatic castration-resistant prostate cancer | Phase 1 | France | 01 Mar 2016 | |
Metastatic castration-resistant prostate cancer | Phase 1 | Spain | 01 Mar 2016 | |
Metastatic castration-resistant prostate cancer | Phase 1 | United Kingdom | 01 Mar 2016 |
Phase 1 | 56 | tjpmrwconr(spwusookaa) = zsvbqbtesr cdlkcamrhd (mwurvkydki ) View more | Positive | 28 May 2021 |